Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study
Sam Keaveney(Royal Marsden NHS Foundation Trust), Christina Messiou(Institute of Cancer Research), Erica Scurr(Royal Marsden NHS Foundation Trust), Matthew Blackledge(Institute of Cancer Research), Antonio Candito(Institute of Cancer Research), Arnold Drury(Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust), Gordon Cook(University of Leeds), Dow‐Mu Koh(Royal Marsden NHS Foundation Trust), Joshua Shur(Royal Marsden NHS Foundation Trust), Winston J. Rennie(Leicester Royal Infirmary), Guy Pratt(University Hospitals Birmingham NHS Foundation Trust), Alina Dragan(Royal Marsden NHS Foundation Trust), Mauro Albrizio(Nottingham University Hospitals NHS Trust), Suchi Gaba(Royal Stoke University Hospital), Anjumara Nilak(Worcestershire Acute Hospitals NHS Trust), Paul Malcolm(Norfolk and Norwich University Hospital), Sarah Brown(University of Leeds), Martin Kaiser(Royal Marsden NHS Foundation Trust), Mihaela Rata(Royal Marsden Hospital), Núria Porta, Sadie Roberts(University of Leeds), Matthew Jenner(University Hospital Southampton NHS Foundation Trust), Alexander King(University Hospital Southampton NHS Foundation Trust), Sanjay Gandhi(Teva Pharmaceuticals (United States)), Amy Davis(Epsom and St Helier University Hospitals NHS Trust), Jessica Winfield(University Hospitals Birmingham NHS Foundation Trust), Priya Suresh(University Hospitals Plymouth NHS Trust), Aarti Abhishek Shah(Manipal Academy of Higher Education)
Cited by 15
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657